167 related articles for article (PubMed ID: 7188232)
1. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
Germá Lluch JR; Marcuello Gaspar E; de Andrés Basauri L; López Pousa A; López López JJ
Rev Esp Oncol; 1982; 29(2):317-24. PubMed ID: 7188232
[TBL] [Abstract][Full Text] [Related]
2. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
[TBL] [Abstract][Full Text] [Related]
3. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
Uekado Y
Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
7. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma.
Daliani DD; Assikis V; Tu SM; Papandreou CN; Pagliaro LC; Holtkamp T; Wang X; Thall PF; Logothetis CJ
Cancer; 2003 Feb; 97(3):561-7. PubMed ID: 12548597
[TBL] [Abstract][Full Text] [Related]
9. [Advanced cancer of the prostate: chemotherapy].
Garcia-Giralt E; Palangie T; Dorval T; Jouve M; Pouillart P
Bull Cancer; 1986; 73(1):68-73. PubMed ID: 3779125
[TBL] [Abstract][Full Text] [Related]
10. A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
Seifter EJ; Bunn PA; Cohen MH; Makuch RW; Dunnick NR; Javadpour N; Bensimon H; Eddy JL; Minna JD; Ihde DC
J Clin Oncol; 1986 Sep; 4(9):1365-73. PubMed ID: 2943877
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
Hellerstedt B; Pienta KJ; Redman BG; Esper P; Dunn R; Fardig J; Olson K; Smith DC
Cancer; 2003 Oct; 98(8):1603-10. PubMed ID: 14534875
[TBL] [Abstract][Full Text] [Related]
12. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
Tunn UW; Goldschmidt AJ; Peter K; Becker M
Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
[No Abstract] [Full Text] [Related]
13. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
[TBL] [Abstract][Full Text] [Related]
14. [Combination hormone-chemotherapy versus hormone therapy alone in the initial treatment of advanced prostate carcinoma--a prospective cooperative study].
Gorski J; Böhm WD; Illig HD; Koch R
Urologe A; 1988 Sep; 27(5):287-90. PubMed ID: 3051628
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced prostatic cancer presenting as inguinal mass].
Ikeda K; Niwa N; Oka F; Ito H; Abe H; Nakagami Y
Hinyokika Kiyo; 1991 Jul; 37(7):765-7. PubMed ID: 1927782
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of stage D prostate cancer patients with hormones in combination with cyclophosphamide].
Fujii A; Yasuno H; Kawaida T; Nakamura I
Hinyokika Kiyo; 1986 Nov; 32(11):1713-7. PubMed ID: 2435128
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
19. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
Servadio C
Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
[No Abstract] [Full Text] [Related]
20. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
Azuma H; Sakamoto T; Kiyama S; Ubai T; Kotake Y; Inamoto T; Takahara K; Nishimura Y; Segawa N; Katsuoka Y
Am J Clin Oncol; 2008 Apr; 31(2):188-94. PubMed ID: 18391605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
